iMethod Application for Quantitation of Trastuzumab in Rat Plasma 1.0
For research use only. Not for use in diagnostic procedures.
Trastuzumab plays a major role in treating breast cancer by interfering with HER2/neu receptor. Quantification of Trastuzumab requires development of reliable, robust, and sensitive bioanalytical assays in biological matrices, which in turn enable better understanding of the efficacy of this biotherapeutic, and hence, offer better treatment protocols.
As the leader of Bioanalysis using LC-MS technology, SCIEX has developed a robust, sensitive, and reproducible bioanalytical method for Trastuzumab. SCIEX users can implement this method readily and avoid long method development times for biologics.